epithalon w tabletkach — 3mg Capsules (30 Count) | Longevity Bioregulator EPITHALON

EGFR and c-MET have in common similar downstream pathways: MAPK (RAS/Rapidly accelerating fibrosarcoma (RAF)/ MAP kinase kinases (MEK)/ERK) and PI3K/AKT/mechanistic target of rapamycin (mTOR)

human evidence is limited and dated, with no standardized dosing established

Liao X, Zeng Q, Xie L, et al

No oncological concerns specific to the TREK-1 blockade mechanism have been identified

Insufficient or disorganized TJ complex formation, an expression of claudin-1 with decreased levels of claudin-5 trans interaction, and claudin-5/ZO-1 interaction in leaky vessels (219) are among the proposed mechanisms behind an incomplete recovery of BBB permeability

Drug interactions have not been extensively studied, warranting caution when combined with immunomodulatory or anticoagulant medications